The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has been discovered that the immune system could be manipulated to influence cancerous cells to destroy itself.
The global Cancer Gene Therapy market was valued at US$ 522 million in 2023 and is anticipated to reach US$ 1657.7 million by 2030, witnessing a CAGR of 17.8% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cancer Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Gene Therapy.
Report Scope
The Cancer Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Adaptimmune
- Bluebird bio
- Celgene
- Shanghai Sunway Biotech
- Shenzhen SiBiono GeneTech
- SynerGene Therapeutics
- Altor BioScience
- Amgen
- Argenx
- BioCancell
- GlaxoSmithKline
- Merck
- OncoGenex Pharmaceuticals
- Transgene
Segment by Type
- Oncolytic Virotherapy
- Gene Transfer
- Gene-Induced Immunotherapy
Segment by Application
- Hospitals
- Diagnostics Centers
- Research Institutes
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncolytic Virotherapy
1.2.3 Gene Transfer
1.2.4 Gene-Induced Immunotherapy
1.3 Market by Application
1.3.1 Global Cancer Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Gene Therapy Market Perspective (2019-2030)
2.2 Cancer Gene Therapy Growth Trends by Region
2.2.1 Global Cancer Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cancer Gene Therapy Historic Market Size by Region (2019-2024)
2.2.3 Cancer Gene Therapy Forecasted Market Size by Region (2025-2030)
2.3 Cancer Gene Therapy Market Dynamics
2.3.1 Cancer Gene Therapy Industry Trends
2.3.2 Cancer Gene Therapy Market Drivers
2.3.3 Cancer Gene Therapy Market Challenges
2.3.4 Cancer Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Gene Therapy Players by Revenue
3.1.1 Global Top Cancer Gene Therapy Players by Revenue (2019-2024)
3.1.2 Global Cancer Gene Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Cancer Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Gene Therapy Revenue
3.4 Global Cancer Gene Therapy Market Concentration Ratio
3.4.1 Global Cancer Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Gene Therapy Revenue in 2023
3.5 Cancer Gene Therapy Key Players Head office and Area Served
3.6 Key Players Cancer Gene Therapy Product Solution and Service
3.7 Date of Enter into Cancer Gene Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Gene Therapy Breakdown Data by Type
4.1 Global Cancer Gene Therapy Historic Market Size by Type (2019-2024)
4.2 Global Cancer Gene Therapy Forecasted Market Size by Type (2025-2030)
5 Cancer Gene Therapy Breakdown Data by Application
5.1 Global Cancer Gene Therapy Historic Market Size by Application (2019-2024)
5.2 Global Cancer Gene Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cancer Gene Therapy Market Size (2019-2030)
6.2 North America Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cancer Gene Therapy Market Size by Country (2019-2024)
6.4 North America Cancer Gene Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Gene Therapy Market Size (2019-2030)
7.2 Europe Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cancer Gene Therapy Market Size by Country (2019-2024)
7.4 Europe Cancer Gene Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Gene Therapy Market Size (2019-2030)
8.2 Asia-Pacific Cancer Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cancer Gene Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Cancer Gene Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Gene Therapy Market Size (2019-2030)
9.2 Latin America Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cancer Gene Therapy Market Size by Country (2019-2024)
9.4 Latin America Cancer Gene Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Gene Therapy Market Size (2019-2030)
10.2 Middle East & Africa Cancer Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cancer Gene Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Cancer Gene Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Detail
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune Cancer Gene Therapy Introduction
11.1.4 Adaptimmune Revenue in Cancer Gene Therapy Business (2019-2024)
11.1.5 Adaptimmune Recent Development
11.2 Bluebird bio
11.2.1 Bluebird bio Company Detail
11.2.2 Bluebird bio Business Overview
11.2.3 Bluebird bio Cancer Gene Therapy Introduction
11.2.4 Bluebird bio Revenue in Cancer Gene Therapy Business (2019-2024)
11.2.5 Bluebird bio Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Cancer Gene Therapy Introduction
11.3.4 Celgene Revenue in Cancer Gene Therapy Business (2019-2024)
11.3.5 Celgene Recent Development
11.4 Shanghai Sunway Biotech
11.4.1 Shanghai Sunway Biotech Company Detail
11.4.2 Shanghai Sunway Biotech Business Overview
11.4.3 Shanghai Sunway Biotech Cancer Gene Therapy Introduction
11.4.4 Shanghai Sunway Biotech Revenue in Cancer Gene Therapy Business (2019-2024)
11.4.5 Shanghai Sunway Biotech Recent Development
11.5 Shenzhen SiBiono GeneTech
11.5.1 Shenzhen SiBiono GeneTech Company Detail
11.5.2 Shenzhen SiBiono GeneTech Business Overview
11.5.3 Shenzhen SiBiono GeneTech Cancer Gene Therapy Introduction
11.5.4 Shenzhen SiBiono GeneTech Revenue in Cancer Gene Therapy Business (2019-2024)
11.5.5 Shenzhen SiBiono GeneTech Recent Development
11.6 SynerGene Therapeutics
11.6.1 SynerGene Therapeutics Company Detail
11.6.2 SynerGene Therapeutics Business Overview
11.6.3 SynerGene Therapeutics Cancer Gene Therapy Introduction
11.6.4 SynerGene Therapeutics Revenue in Cancer Gene Therapy Business (2019-2024)
11.6.5 SynerGene Therapeutics Recent Development
11.7 Altor BioScience
11.7.1 Altor BioScience Company Detail
11.7.2 Altor BioScience Business Overview
11.7.3 Altor BioScience Cancer Gene Therapy Introduction
11.7.4 Altor BioScience Revenue in Cancer Gene Therapy Business (2019-2024)
11.7.5 Altor BioScience Recent Development
11.8 Amgen
11.8.1 Amgen Company Detail
11.8.2 Amgen Business Overview
11.8.3 Amgen Cancer Gene Therapy Introduction
11.8.4 Amgen Revenue in Cancer Gene Therapy Business (2019-2024)
11.8.5 Amgen Recent Development
11.9 Argenx
11.9.1 Argenx Company Detail
11.9.2 Argenx Business Overview
11.9.3 Argenx Cancer Gene Therapy Introduction
11.9.4 Argenx Revenue in Cancer Gene Therapy Business (2019-2024)
11.9.5 Argenx Recent Development
11.10 BioCancell
11.10.1 BioCancell Company Detail
11.10.2 BioCancell Business Overview
11.10.3 BioCancell Cancer Gene Therapy Introduction
11.10.4 BioCancell Revenue in Cancer Gene Therapy Business (2019-2024)
11.10.5 BioCancell Recent Development
11.11 GlaxoSmithKline
11.11.1 GlaxoSmithKline Company Detail
11.11.2 GlaxoSmithKline Business Overview
11.11.3 GlaxoSmithKline Cancer Gene Therapy Introduction
11.11.4 GlaxoSmithKline Revenue in Cancer Gene Therapy Business (2019-2024)
11.11.5 GlaxoSmithKline Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Cancer Gene Therapy Introduction
11.12.4 Merck Revenue in Cancer Gene Therapy Business (2019-2024)
11.12.5 Merck Recent Development
11.13 OncoGenex Pharmaceuticals
11.13.1 OncoGenex Pharmaceuticals Company Detail
11.13.2 OncoGenex Pharmaceuticals Business Overview
11.13.3 OncoGenex Pharmaceuticals Cancer Gene Therapy Introduction
11.13.4 OncoGenex Pharmaceuticals Revenue in Cancer Gene Therapy Business (2019-2024)
11.13.5 OncoGenex Pharmaceuticals Recent Development
11.14 Transgene
11.14.1 Transgene Company Detail
11.14.2 Transgene Business Overview
11.14.3 Transgene Cancer Gene Therapy Introduction
11.14.4 Transgene Revenue in Cancer Gene Therapy Business (2019-2024)
11.14.5 Transgene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
